Cardiovascular safety and efficacy of the combined symptomatic slow-acting drug glucosamine and chondroitin sulfate in patients with gonarthrosis
Objective: to investigate the clinical efficacy and cardiovascular safety of the combined symptomatic slow-acting drug glucosamine and chondroitin sulfate in patients with osteoarthritis (OA) and hypertension.Subjects and methods. The investigation enrolled 44 patients (a female:male ratio of 40:4)...
Saved in:
Main Authors: | A. P. Rebrov, I. A. Romanova, I. Z. Gaydukova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2016-06-01
|
Series: | Современная ревматология |
Subjects: | |
Online Access: | https://mrj.ima-press.net/mrj/article/view/682 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The efficacy and tolerability of the slow-acting combined agent glucosamine and chondroitin sulfate in gonarthrosis patients tacking no nonsteroidal anti-inflammatory drugs
by: A. P. Rebrov, et al.
Published: (2016-01-01) -
Comparison of Glucosamine-Chondroitin Sulfate with and without Methylsulfonylmethane in Grade I-II Knee Osteoarthritis: A Double Blind Randomized Controlled Trial
by: Andri M.T. Lubis, et al.
Published: (2017-08-01) -
Comparison of Glucosamine-Chondroitin Sulfate with and without Methylsulfonylmethane in Grade I-II Knee Osteoarthritis: A Double Blind Randomized Controlled Trial
by: Andri M.T. Lubis, et al.
Published: (2017-08-01) -
Perioperative pharmacotherapy for endoprosthetics: potential of chondroitin sulfate and glucosamine sulfate
by: I. Yu. Torshin, et al.
Published: (2022-04-01) -
Knee osteoarthrosis: Clinical presentation, diagnosis, treatment
by: Vladimir Vasilyevich Badokin
Published: (2013-10-01)